Noradrenaline augments tetanic potentiation of transmitter release by a calcium dependent process

Brain Res. 1981 Jun 9;214(1):200-4. doi: 10.1016/0006-8993(81)90455-8.

Abstract

Noradrenaline (25 microM-50 microM) causes an increase in tetanic potentiation and in the augmentation phase of posttetanic potentiation of miniature and plate potential frequency. These effects were observed at both the frog and the rat neuromuscular junctions. The action of noradrenaline on quantal transmitter release depends on the presence of calcium ions in the extracellular medium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / pharmacology*
  • Electric Stimulation
  • Evoked Potentials / drug effects
  • Neuromuscular Junction / drug effects*
  • Norepinephrine / pharmacology*
  • Rana pipiens
  • Rats
  • Synapses / drug effects
  • Synaptic Transmission / drug effects*

Substances

  • Calcium
  • Norepinephrine